John J. Osterholzer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
John J. Osterholzer has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Michal A. Olszewski
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA
11 shared publications Gwo-Hsiao Chen
‡Research Service, Ann Arbor VA Health System, Department of Veterans Affairs Health System, University of Michigan Health System, Ann Arbor, MI
7 shared publicationsSeagal Teitz-Tennenbaum
Research Service and Pulmonary Section Medical Service, Veterans Affairs Ann Arbor Health System
7 shared publicationsGary B. Huffnagle
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
5 shared publications- Benjamin J. Murdock
Department of Neurology University of Michigan Ann Arbor Michigan USA
4 shared publications Galen B. Toews
Pulmonary Section, Medical Service, Ann Arbor Veterans Affairs Health System, Ann Arbor, Michigan
4 shared publications
Latest Publications
- 26 June 2026
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 23 (9) , 1235-1256
Deployment-Related Respiratory Health: Bridging the Gap between Clinical and Epidemiological Associations and Disease Mechanisms An Official American Thoracic Society Workshop Report
Land-based military deployers to Afghanistan and/or Southwest Asia (SWA) encountered exposure to high concentrations of respirable particulate matter (PM) from multiple sources, including desert dust, burn pit smoke, and military occupations. Adverse lung health effects following deployment have been noted, including upper and lower respiratory tract symptoms, asthma, and small airway and other abnormalities on lung biopsy. The American Thoracic Society (ATS) convened a Workshop in 2018 to review studies assessing post-deployment respiratory health, describe emerging research, and highlight knowledge gaps. Progress on understanding post-deployment health prompted a second ATS Workshop to update current knowledge by 1) reviewing new studies linking exposure assessments to symptoms and/or clinical disease; 2) describing the spectrum of lung pathology reported in previously deployed personnel; 3) evaluating current knowledge of long-term health outcomes after deployment; 4) reviewing data from recent experimental models of deployment-related respiratory diseases (DRRDs); and 5) providing recommendations for future research priorities. Workshop participants agreed that there is substantial evidence linking deployment-related exposures to respiratory symptoms, pulmonary diagnoses, and lung pathology. Knowledge gaps include understanding: 1) the extent and mechanisms through which specific exposures result in impaired pulmonary function, small airways disease, and potentially future chronic pulmonary diseases; 2) the contribution of exposure-related foreign material in the lung to clinical and pathologic findings; and 3) the relationship of pathologic findings to respiratory health, especially those involving small airways.
- 26 June 2026
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 23 (9) , 1235-1256
Deployment-Related Respiratory Health: Bridging the Gap between Clinical and Epidemiological Associations and Disease Mechanisms An Official American Thoracic Society Workshop Report
Land-based military deployers to Afghanistan and/or Southwest Asia (SWA) encountered exposure to high concentrations of respirable particulate matter (PM) from multiple sources, including desert dust, burn pit smoke, and military occupations. Adverse lung health effects following deployment have been noted, including upper and lower respiratory tract symptoms, asthma, and small airway and other abnormalities on lung biopsy. The American Thoracic Society (ATS) convened a Workshop in 2018 to review studies assessing post-deployment respiratory health, describe emerging research, and highlight knowledge gaps. Progress on understanding post-deployment health prompted a second ATS Workshop to update current knowledge by 1) reviewing new studies linking exposure assessments to symptoms and/or clinical disease; 2) describing the spectrum of lung pathology reported in previously deployed personnel; 3) evaluating current knowledge of long-term health outcomes after deployment; 4) reviewing data from recent experimental models of deployment-related respiratory diseases (DRRDs); and 5) providing recommendations for future research priorities. Workshop participants agreed that there is substantial evidence linking deployment-related exposures to respiratory symptoms, pulmonary diagnoses, and lung pathology. Knowledge gaps include understanding: 1) the extent and mechanisms through which specific exposures result in impaired pulmonary function, small airways disease, and potentially future chronic pulmonary diseases; 2) the contribution of exposure-related foreign material in the lung to clinical and pathologic findings; and 3) the relationship of pathologic findings to respiratory health, especially those involving small airways.
- Open Access
- 16 March 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1761783
Development of peribronchiolar fibrosis is associated with local immune and MAPK pathway activation in a murine model of deployment-related constrictive bronchiolitis
Background and aim: Deployment-related constrictive bronchiolitis (DRCB), a chronic fibrotic small airway disease, has been reported in military personnel following deployment to Southwest Asia and Afghanistan. Veterans diagnosed with DRCB indicate exposure to inhalational hazards, yet the molecular pathophysiology of this disorder remains enigmatic. Club cells are local progenitors critical for repair of small airway epithelium after inhalational injury. We have previously modeled DRCB using transgenic CC-DTA mice in which sustained club cell injury induces murine constrictive bronchiolitis (mCB) that recapitulates many of the histopathologic abnormalities observed in DRCB including peribronchiolar inflammation and fibrosis. The aim of the current study was to identify molecular pathways activated at the site of injury during the development of mCB. Methods: CC-DTA and control mice were exposed to doxycycline on protocol day 0–10 to induce club cell injury. Protein digital spatial profiling restricted to small airways was performed on lung sections harvested on protocol day 0, 10, and 20 and targeted a panel of 57 proteins focused on immune modulation and MAPK signaling. Results: Sustained club cell injury mediated small airway wall thickening due to enhanced deposition of subepithelial collagen fibers. Principal component analysis separated small airways of CC-DTA from control mice on day 10 and 20. Upregulated protein expression in small airways of CC-DTA versus control mice was found to be most numerous and prominent on day 20 and included an array of proteins involved in myeloid or lymphoid cell activation, signal transduction in response to extracellular stress stimuli, and regulation of cell proliferation, differentiation and survival. Immunofluorescence validated an increase in programmed death-ligand 1 + (PD-L1 + ) cells and in phosphorylated-p90 ribosomal S6 kinase + (p-p90RSK + , a downstream effector of the MAPK/ERK pathway) epithelial cells in response to sustained club cell injury. Conclusion: We identified features of chronic innate and adaptive immune activation and aberrant collagen deposition within injured small airways during the development of mCB. Further, our findings implicate the PD-1/PD-L1 axis and the MAPK/ERK pathway in the pathogenesis of DRCB and may reveal potential therapeutic targets for combating this disease.
- 16 March 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 14, 1761783
Open AccessDevelopment of peribronchiolar fibrosis is associated with local immune and MAPK pathway activation in a murine model of deployment-related constrictive bronchiolitis
Background and aim: Deployment-related constrictive bronchiolitis (DRCB), a chronic fibrotic small airway disease, has been reported in military personnel following deployment to Southwest Asia and Afghanistan. Veterans diagnosed with DRCB indicate exposure to inhalational hazards, yet the molecular pathophysiology of this disorder remains enigmatic. Club cells are local progenitors critical for repair of small airway epithelium after inhalational injury. We have previously modeled DRCB using transgenic CC-DTA mice in which sustained club cell injury induces murine constrictive bronchiolitis (mCB) that recapitulates many of the histopathologic abnormalities observed in DRCB including peribronchiolar inflammation and fibrosis. The aim of the current study was to identify molecular pathways activated at the site of injury during the development of mCB. Methods: CC-DTA and control mice were exposed to doxycycline on protocol day 0–10 to induce club cell injury. Protein digital spatial profiling restricted to small airways was performed on lung sections harvested on protocol day 0, 10, and 20 and targeted a panel of 57 proteins focused on immune modulation and MAPK signaling. Results: Sustained club cell injury mediated small airway wall thickening due to enhanced deposition of subepithelial collagen fibers. Principal component analysis separated small airways of CC-DTA from control mice on day 10 and 20. Upregulated protein expression in small airways of CC-DTA versus control mice was found to be most numerous and prominent on day 20 and included an array of proteins involved in myeloid or lymphoid cell activation, signal transduction in response to extracellular stress stimuli, and regulation of cell proliferation, differentiation and survival. Immunofluorescence validated an increase in programmed death-ligand 1 + (PD-L1 + ) cells and in phosphorylated-p90 ribosomal S6 kinase + (p-p90RSK + , a downstream effector of the MAPK/ERK pathway) epithelial cells in response to sustained club cell injury. Conclusion: We identified features of chronic innate and adaptive immune activation and aberrant collagen deposition within injured small airways during the development of mCB. Further, our findings implicate the PD-1/PD-L1 axis and the MAPK/ERK pathway in the pathogenesis of DRCB and may reveal potential therapeutic targets for combating this disease.
- Open Access
- 21 May 2025
- Published by Springer Nature in Respiratory Research
- Vol. 26 (1) , 1-11
Use of quantitative CT chest imaging to derive and assess a radiographic phenotype of deployment-related constrictive bronchiolitis
Background: Efforts to phenotype veterans that developed respiratory symptoms following deployments to the Southwest Asia Theater of Military Operation have been limited by the insensitivity of current non-invasive testing to objectively identify deployment-related constrictive bronchiolitis and other features of chronic lung injury. In this study, we derived a quantitative CT (QCT)-based radiographic phenotype of biopsy-proven deployment-related constrictive bronchiolitis (DRCB) and assessed its ability to assist in the phenotyping of non-biopsied formerly deployed symptomatic veterans. Methods: QCT analysis combined with demographic, physiologic, symptom, and exposure data was obtained from three cohorts: military personnel with biopsy-proven deployment-related constrictive bronchiolitis (DRCB, n = 37), formerly deployed symptomatic veterans (FDSV, n = 71), and asymptomatic civilians (Control, n = 98). Differences in unadjusted QCT metrics and demographic variables between cohorts were identified and further assessed by principal component analysis. Thereafter, adjusted data from the DRCB cohort was used to derive a QCT-based radiographic phenotype of DRCB expressed as a DRCB-Probability Index (DRCB-PI). Application of the DRCB-PI to the FDSV cohort was used to assess additional phenotypic metrics associated with the DRCB phenotype (DRCB-PI > 0.5). Results: Individual unadjusted QCT metrics for functional small airways disease and high attenuation area were elevated in DRCB and FDSV cohorts (relative to Control). Primary component analysis revealed that DRCB and FDSV cohorts overlapped and were distinguished from the Control cohort. The FDSV subjects whose DRCB-PI was > 0.5 had greater evidence of small airways disease (assessed by oscillometry and QCT) and self-reported more intense immediate health effects to their exposures to military burn pit smoke, and sand and dust. Conclusions: Application of a QCT-derived radiographic phenotype of DRCB identified a subset of veterans with evidence of abnormal small airways and more severe self-reported health effects following inhalational exposures during military deployment. Future studies incorporating QCT may help establish non-invasive strategies to detect DRCB and other forms of chronic lung injury.
- 21 May 2025
- Published by Springer Nature in Respiratory Research
- Vol. 26 (1) , 1-11
Open AccessUse of quantitative CT chest imaging to derive and assess a radiographic phenotype of deployment-related constrictive bronchiolitis
Background: Efforts to phenotype veterans that developed respiratory symptoms following deployments to the Southwest Asia Theater of Military Operation have been limited by the insensitivity of current non-invasive testing to objectively identify deployment-related constrictive bronchiolitis and other features of chronic lung injury. In this study, we derived a quantitative CT (QCT)-based radiographic phenotype of biopsy-proven deployment-related constrictive bronchiolitis (DRCB) and assessed its ability to assist in the phenotyping of non-biopsied formerly deployed symptomatic veterans. Methods: QCT analysis combined with demographic, physiologic, symptom, and exposure data was obtained from three cohorts: military personnel with biopsy-proven deployment-related constrictive bronchiolitis (DRCB, n = 37), formerly deployed symptomatic veterans (FDSV, n = 71), and asymptomatic civilians (Control, n = 98). Differences in unadjusted QCT metrics and demographic variables between cohorts were identified and further assessed by principal component analysis. Thereafter, adjusted data from the DRCB cohort was used to derive a QCT-based radiographic phenotype of DRCB expressed as a DRCB-Probability Index (DRCB-PI). Application of the DRCB-PI to the FDSV cohort was used to assess additional phenotypic metrics associated with the DRCB phenotype (DRCB-PI > 0.5). Results: Individual unadjusted QCT metrics for functional small airways disease and high attenuation area were elevated in DRCB and FDSV cohorts (relative to Control). Primary component analysis revealed that DRCB and FDSV cohorts overlapped and were distinguished from the Control cohort. The FDSV subjects whose DRCB-PI was > 0.5 had greater evidence of small airways disease (assessed by oscillometry and QCT) and self-reported more intense immediate health effects to their exposures to military burn pit smoke, and sand and dust. Conclusions: Application of a QCT-derived radiographic phenotype of DRCB identified a subset of veterans with evidence of abnormal small airways and more severe self-reported health effects following inhalational exposures during military deployment. Future studies incorporating QCT may help establish non-invasive strategies to detect DRCB and other forms of chronic lung injury.
- Open Access
- 29 April 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (11)
PAI-1 interaction with sortilin-related receptor 1 is required for lung fibrosis
Mutation studies of plasminogen activator inhibitor 1 (PAI-1) have previously implied that PAI-1 promotes lung fibrosis via a vitronectin-dependent (VTN-dependent) mechanism. In the present study, employing 2 distinct murine fibrosis models and VTN-deficient mice, we found that VTN is not required for PAI-1 to drive lung scarring. This result suggested the existence of a profibrotic interaction involving the VTN-binding site on PAI-1 with an unidentified ligand. Using an unbiased proteomic approach, we identified sortilin-related receptor 1 (SorLA) as the most highly enriched PAI-1 binding partner in the fibrosing lung. Investigating the role of SorLA in pulmonary fibrosis demonstrated that deficiency of this protein protected against lung scarring in a murine model. We further found that SorLA is required for PAI-1 to promote scarring in mice, that both SorLA and PAI-1 protein levels are increased in human idiopathic pulmonary fibrosis (IPF) explants, and that these proteins are associated in IPF tissue. Finally, confocal microscopy showed that expression of SorLA in CHO cells increased cellular uptake of PAI-1, and these proteins colocalized in the cytoplasm. Together, these data elucidate a mechanism by which the potent profibrotic mediator PAI-1 drives lung fibrosis and implicate SorLA as a potential therapeutic target in IPF treatment.
- 29 April 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (11)
Open AccessPAI-1 interaction with sortilin-related receptor 1 is required for lung fibrosis
Mutation studies of plasminogen activator inhibitor 1 (PAI-1) have previously implied that PAI-1 promotes lung fibrosis via a vitronectin-dependent (VTN-dependent) mechanism. In the present study, employing 2 distinct murine fibrosis models and VTN-deficient mice, we found that VTN is not required for PAI-1 to drive lung scarring. This result suggested the existence of a profibrotic interaction involving the VTN-binding site on PAI-1 with an unidentified ligand. Using an unbiased proteomic approach, we identified sortilin-related receptor 1 (SorLA) as the most highly enriched PAI-1 binding partner in the fibrosing lung. Investigating the role of SorLA in pulmonary fibrosis demonstrated that deficiency of this protein protected against lung scarring in a murine model. We further found that SorLA is required for PAI-1 to promote scarring in mice, that both SorLA and PAI-1 protein levels are increased in human idiopathic pulmonary fibrosis (IPF) explants, and that these proteins are associated in IPF tissue. Finally, confocal microscopy showed that expression of SorLA in CHO cells increased cellular uptake of PAI-1, and these proteins colocalized in the cytoplasm. Together, these data elucidate a mechanism by which the potent profibrotic mediator PAI-1 drives lung fibrosis and implicate SorLA as a potential therapeutic target in IPF treatment.
- Open Access
- 1 February 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (2) , 310-311
Reply to Holley and Morris: Postdeployment Respiratory Health: It’s Not Always the Lungs
- 1 February 2025
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 22 (2) , 310-311
Open AccessReply to Holley and Morris: Postdeployment Respiratory Health: It’s Not Always the Lungs
- Open Access
- 24 January 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (1) , e0313992
Sulfur dioxide exposure of mice induces peribronchiolar fibrosis—A defining feature of deployment-related constrictive bronchiolitis
Deployment-related constrictive bronchiolitis (DRCB) has emerged as a health concern in military personnel returning from Southwest Asia. Exposure to smoke from a fire at the Al-Mishraq sulfur enrichment facility and/or burn pits was reported by a subset of Veterans diagnosed with this disorder. DRCB is characterized by thickening and fibrosis of small airways (SA) in the lung, but whether these are related to toxin inhalation remains uncertain. The aim of this study was to determine whether sulfur dioxide (SO2) exposure can induce histopathological features of DRCB. C57BL/6J mice were exposed to 50 ± 5 ppm SO2 for one hour/day for five consecutive days. Lungs from exposed and unexposed mice were evaluated on day 5, 10, and 20. Lung sections were stained using hematoxylin and eosin, Masson’s trichrome, picrosirius red (PSR), and immunofluorescence for club cell secretory protein, acetylated-α-tubulin, and Ki67. Small airway wall thickness was determined by morphometric analysis and collagen content was quantified by measuring PSR fluorescence intensity. CurveAlign and CT-FIRE were used to enumerate collagen fibers and assess fibers’ width and length, respectively. Leukocyte subpopulations were quantified by flow cytometry analysis. This protocol of SO2 exposure of mice: 1) Triggered club cell proliferation and differentiation; 2) Increased SA wall thickness by inducing subepithelial collagen deposition; and 3) Increased width, length, and number, but not density, of collagen fibers within the wall of SA. 4) Induced no peribronchiolar inflammation or respiratory bronchiolitis. Collectively, these findings implicate club cell proliferation and differentiation in the profibrotic response to SO2 and identify this SO2 exposure as a potentially effective though imperfect model for studying SA fibrosis in DRCB.
- 24 January 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (1) , e0313992
Open AccessSulfur dioxide exposure of mice induces peribronchiolar fibrosis—A defining feature of deployment-related constrictive bronchiolitis
Deployment-related constrictive bronchiolitis (DRCB) has emerged as a health concern in military personnel returning from Southwest Asia. Exposure to smoke from a fire at the Al-Mishraq sulfur enrichment facility and/or burn pits was reported by a subset of Veterans diagnosed with this disorder. DRCB is characterized by thickening and fibrosis of small airways (SA) in the lung, but whether these are related to toxin inhalation remains uncertain. The aim of this study was to determine whether sulfur dioxide (SO2) exposure can induce histopathological features of DRCB. C57BL/6J mice were exposed to 50 ± 5 ppm SO2 for one hour/day for five consecutive days. Lungs from exposed and unexposed mice were evaluated on day 5, 10, and 20. Lung sections were stained using hematoxylin and eosin, Masson’s trichrome, picrosirius red (PSR), and immunofluorescence for club cell secretory protein, acetylated-α-tubulin, and Ki67. Small airway wall thickness was determined by morphometric analysis and collagen content was quantified by measuring PSR fluorescence intensity. CurveAlign and CT-FIRE were used to enumerate collagen fibers and assess fibers’ width and length, respectively. Leukocyte subpopulations were quantified by flow cytometry analysis. This protocol of SO2 exposure of mice: 1) Triggered club cell proliferation and differentiation; 2) Increased SA wall thickness by inducing subepithelial collagen deposition; and 3) Increased width, length, and number, but not density, of collagen fibers within the wall of SA. 4) Induced no peribronchiolar inflammation or respiratory bronchiolitis. Collectively, these findings implicate club cell proliferation and differentiation in the profibrotic response to SO2 and identify this SO2 exposure as a potentially effective though imperfect model for studying SA fibrosis in DRCB.
- 1 November 2024
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 21 (11) , 1471-1473
A “Quest for Answers” in the Emerging Field of Postdeployment Respiratory Health
- 1 November 2024
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 21 (11) , 1471-1473
A “Quest for Answers” in the Emerging Field of Postdeployment Respiratory Health
- 1 March 2023
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 20 (3) , 354-357
A Sacred Obligation: Meeting the Needs of Veterans with Airborne Hazard Exposures
- 1 March 2023
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 20 (3) , 354-357
A Sacred Obligation: Meeting the Needs of Veterans with Airborne Hazard Exposures